Adial Pharmaceuticals Files Q1 2025 10-Q
Ticker: ADIL · Form: 10-Q · Filed: May 14, 2025 · CIK: 1513525
| Field | Detail |
|---|---|
| Company | Adial Pharmaceuticals, Inc. (ADIL) |
| Form Type | 10-Q |
| Filed Date | May 14, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, quarterly-report, pharmaceuticals
TL;DR
Adial Pharma filed its Q1 2025 10-Q. Check financials.
AI Summary
Adial Pharmaceuticals, Inc. filed its quarterly report on Form 10-Q for the period ended March 31, 2025. The company, incorporated in Delaware, is focused on pharmaceutical preparations. Its principal executive offices are located in Glen Allen, VA.
Why It Matters
This filing provides an update on Adial Pharmaceuticals' financial and operational status for the first quarter of 2025, which is crucial for investors to assess the company's performance and outlook.
Risk Assessment
Risk Level: low — This is a standard quarterly filing providing routine financial and operational updates.
Key Players & Entities
- ADIAL PHARMACEUTICALS, INC. (company) — Registrant
- March 31, 2025 (date) — Quarterly period end date
- Delaware (jurisdiction) — State of incorporation
- Glen Allen, VA (location) — Address of Principal Executive Offices
- 001-38323 (identifier) — Commission File Number
FAQ
What is the exact period covered by this 10-Q filing?
This 10-Q filing covers the quarterly period ended March 31, 2025.
What is the company's full legal name as stated in the filing?
The company's full legal name is ADIAL PHARMACEUTICALS, INC.
In which state was Adial Pharmaceuticals, Inc. incorporated?
Adial Pharmaceuticals, Inc. was incorporated in Delaware.
What is the address of Adial Pharmaceuticals' principal executive offices?
The address of Adial Pharmaceuticals' principal executive offices is 4870 Sadler Road, Suite 300, Glen Allen, VA 23060.
What is the Commission File Number for Adial Pharmaceuticals, Inc.?
The Commission File Number for Adial Pharmaceuticals, Inc. is 001-38323.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 14, 2025 regarding ADIAL PHARMACEUTICALS, INC. (ADIL).